Literature DB >> 21113243

Hippocratic psychopharmacology for Bipolar Disorder-An Expert's Opinion.

S Nassir Ghaemi1.   

Abstract

In the case of bipolar disorder, my experience is that differences of opinion among clinicians and researchers often have little to do with data and much more to do with underlying beliefs about psychopharmacology. In this review, I will inevitably discuss data, but I also will examine differing philosophies of psychopharmacology that influence how we interpret and use those data.

Entities:  

Year:  2006        PMID： 21113243      PMCID： PMC2991080     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


  27 in total

1.  On defining 'mood stabilizer'.

Authors:  S N Ghaemi
Journal:  Bipolar Disord       Date:  2001-06       Impact factor: 6.744

2.  Research reports on treatments for bipolar disorder: preliminary assessment of methodological quality.

Authors:  F Soldani; S N Ghaemi; R J Baldessarini
Journal:  Acta Psychiatr Scand       Date:  2005-07       Impact factor: 6.392

3.  Benjamin Rush, MD: assassin or beloved healer?

Authors:  R L North
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-01

4.  A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.

Authors:  C L Bowden; J R Calabrese; S L McElroy; L Gyulai; A Wassef; F Petty; H G Pope; J C Chou; P E Keck; L J Rhodes; A C Swann; R M Hirschfeld; P J Wozniak
Journal:  Arch Gen Psychiatry       Date:  2000-05

Review 5.  Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

Authors:  H K Manji; G J Moore; G Chen
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

Review 6.  Carbamazepine clinical pharmacology: a review.

Authors:  F Albani; R Riva; A Baruzzi
Journal:  Pharmacopsychiatry       Date:  1995-11       Impact factor: 5.788

Review 7.  Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis.

Authors:  L Tondo; J Hennen; R J Baldessarini
Journal:  Acta Psychiatr Scand       Date:  2001-09       Impact factor: 6.392

8.  Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.

Authors:  Mauricio Tohen; Joseph R Calabrese; Gary S Sachs; Michael D Banov; Holland C Detke; Richard Risser; Robert W Baker; James C-Y Chou; Charles L Bowden
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

9.  Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up.

Authors:  Jules Angst; Felix Angst; Regina Gerber-Werder; Alex Gamma
Journal:  Arch Suicide Res       Date:  2005

Review 10.  Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.

Authors:  John R Geddes; Sally Burgess; Keith Hawton; Kay Jamison; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112
View more
  2 in total

Review 1.  Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.

Authors:  Alexander C Tsai; Nicholas Z Rosenlicht; Jon N Jureidini; Peter I Parry; Glen I Spielmans; David Healy
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

2.  A history of depression in patients attending a chronic pain management clinic in South Africa: A retrospective chart review.

Authors:  Joseph J van Vreede; Romy Parker; Janieke van Nugteren
Journal:  S Afr J Psychiatr       Date:  2022-04-29       Impact factor: 1.242
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.